Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
654.58%Stock Based Compensation Margin
VS
Market
Sector
Industry
History
$ 27.34Close
$ 15.13 - $ 29.72 52-Week Range
Ticker Information
Ticker
CLDXCompany Name
CELLDEX THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCELLDEX THERAPEUTICS INC - Stock Based Compensation Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CLDX - SB Comp % Historical data
| Date | Revenues | Stock Based Compensation | Stock Based Compensation Margin |
|---|---|---|---|
| 6/30/2025 | $ 5.79M | $ 37.91M | 654.58% |
| 3/31/2025 | $ 7.56M | $ 36.36M | 480.96% |
| 12/31/2024 | $ 7.02M | $ 34.24M | 487.78% |
| 9/30/2024 | $ 9.98M | $ 31.67M | 317.5% |
| 6/30/2024 | $ 8.3M | $ 29.18M | 351.42% |
| 3/31/2024 | $ 6.07M | $ 26.75M | 440.58% |
| 12/31/2023 | $ 6.88M | $ 23.89M | 347.09% |
| 9/30/2023 | $ 4.37M | $ 21.19M | 485.36% |
| 6/30/2023 | $ 3.25M | $ 18.56M | 570.23% |
| 3/31/2023 | $ 3.15M | $ 16.8M | 533.27% |
Key Performance Insights, Last 5 Years
- CELLDEX THERAPEUTICS INC's latest trailing twelve months (TTM) SB Comp % stands at 74.02%.
- Over the past 5 years, CELLDEX THERAPEUTICS INC's average SB Comp % has been 450.81%.
- The median SB Comp % for CELLDEX THERAPEUTICS INC during this period was 396%
- CELLDEX THERAPEUTICS INC reached its highest SB Comp % over the past 5 years at 1550.49%.
- The lowest SB Comp % recorded by CELLDEX THERAPEUTICS INC in the same timeframe 52.78%
CELLDEX THERAPEUTICS INC's SB Comp % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SB Comp % Benchmarks
Similar metrics to SB Comp %:
- Stock Based Compensation - [Cash Flow Statement] Stock Based Compensation, also called Share Based Compensation or Equity Compensation, is a method of paying directors, executives and employees with equity in the business. As non-cash expense, this element is added back when calculating net cash generated by operating activities [NCFO].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
Definition of Stock Based Compensation Margin
[Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].SB Comp. / Revenues
(=) SB Comp % SB Comp % for CELLDEX THERAPEUTICS INC is calculated as follows: SB Comp. [ $ 3.35M ] / Revenues [ $ 4.52M ]
(=) SB Comp % [ 74.02% ] CLDX - Stock Based Compensation Margin, Last 5 years
52.78%
Minimum
Dec 31, 2020
1550.49%
Maximum
Jun 30, 2022
450.81%
Average
396%
Median
SB Comp % Benchmark AnalysisMarket
The chart above depicts the distribution of SB Comp % for companies in the Total Stock Market. The average SB Comp % of the companies is 1.72% with a standard deviation of 1.9%.
The following table provides additional summary stats:
SB Comp % in the Market:
| filtered constituents | 2.99K |
|---|---|
| min | -3.97% |
| max | 8.43% |
| average | 1.72% |
| median | 1.04% |
| std | 1.9% |